317 related articles for article (PubMed ID: 31725448)
21. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
[TBL] [Abstract][Full Text] [Related]
22. 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
Elkhatali S; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; El-Kadi AO
Toxicol Appl Pharmacol; 2015 Dec; 289(3):550-9. PubMed ID: 26454030
[TBL] [Abstract][Full Text] [Related]
23. Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.
Pan L; Sheng M; Huang Z; Zhu Z; Xu C; Teng L; He L; Gu C; Yi C; Li J
PLoS One; 2017; 12(10):e0186635. PubMed ID: 29065170
[TBL] [Abstract][Full Text] [Related]
24. Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.
Liu X; Li T; Sun S; Xu F; Wang Y
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H279-85. PubMed ID: 16100249
[TBL] [Abstract][Full Text] [Related]
25. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
[TBL] [Abstract][Full Text] [Related]
26. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
[No Abstract] [Full Text] [Related]
27. Downregulation of salusins alleviates hypertrophic cardiomyopathy via attenuating oxidative stress and autophagy.
Dang JY; Zhang W; Chu Y; Chen JH; Ji ZL; Feng P
Eur J Med Res; 2024 Feb; 29(1):109. PubMed ID: 38336819
[TBL] [Abstract][Full Text] [Related]
28. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
[TBL] [Abstract][Full Text] [Related]
29. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
30. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD
J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351
[TBL] [Abstract][Full Text] [Related]
31. Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.
Zhou D; Liang Q; He X; Zhan C
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):531-4. PubMed ID: 18846332
[TBL] [Abstract][Full Text] [Related]
32. Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.
Ruzicska E; Foldes G; Lako-Futo Z; Sarman B; Wellmann J; Szenasi G; Tulassay Z; Ruskoaho H; Toth M; Somogyi A
J Hypertens; 2004 Jun; 22(6):1191-200. PubMed ID: 15167455
[TBL] [Abstract][Full Text] [Related]
33. [Over-expression of BDNF inhibits angiotensin II-induced apoptosis of cardiomyocytes in SD rats].
Cao J; Wu Y; Liu G; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):218-224. PubMed ID: 29773102
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
Gomes ER; Lara AA; Almeida PW; Guimarães D; Resende RR; Campagnole-Santos MJ; Bader M; Santos RA; Guatimosim S
Hypertension; 2010 Jan; 55(1):153-60. PubMed ID: 19996065
[TBL] [Abstract][Full Text] [Related]
35. Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.
Wang S; Han HM; Pan ZW; Hang PZ; Sun LH; Jiang YN; Song HX; Du ZM; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):823-31. PubMed ID: 22569796
[TBL] [Abstract][Full Text] [Related]
36. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway.
Yang L; Zou X; Liang Q; Chen H; Feng J; Yan L; Wang Z; Zhou D; Li S; Yao S; Zheng Z
Exp Mol Med; 2007 Feb; 39(1):65-73. PubMed ID: 17334230
[TBL] [Abstract][Full Text] [Related]
37. Involvement of phosphatase and tensin homolog-induced putative kinase 1/Parkin-mediated autophagy in angiotensin II-induced cardiac hypertrophy in C57BL/6 mice.
Fan G; Chen MJ; Wei J
J Int Med Res; 2020 May; 48(5):300060519896143. PubMed ID: 31889458
[TBL] [Abstract][Full Text] [Related]
38. Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
Wang HN; Li JL; Xu T; Yao HQ; Chen GH; Hu J
Mol Med Rep; 2020 Aug; 22(2):1342-1350. PubMed ID: 32468001
[TBL] [Abstract][Full Text] [Related]
39. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
[TBL] [Abstract][Full Text] [Related]
40. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
